logo
HHS says it will begin reforms of organ donation system after federal investigation finds ‘horrifying' problems

HHS says it will begin reforms of organ donation system after federal investigation finds ‘horrifying' problems

CNN6 days ago
The US Department of Health and Human Services said Monday that it's undertaking an initiative to reform the country's organ donation system, after a federal investigation found that one organization in the Kentucky region began the process to take organs from people who may not have been dead.
A House subcommittee is holding a hearing Tuesday on organ donation safety lapses and how procurement and transplant organizations intend to improve the system, to regain the trust of donors and their families. That trust is essential because the US organ donation system relies on people to volunteer to donate, often when they get a driver's license.
As of 2022, about 170 million people in the US have signed up to donate their organs when they die, but there is always more demand for organs than what is available. Last year, there were more than 48,000 transplants in the US, but more than 103,000 people were on waiting lists. About 13 people in the United States die every day waiting for a transplant, according to the federal Health Resources and Services Administration.
HHS says the reform initiative was launched after an investigation by the Health Resources and Services Administration found problems with dozens of cases involving incomplete donations – when an organization started the process to take someone's organs but, for some reason, the donation never happened.
According to a report on the federal investigation, as well as a memo prepared ahead of the House subcommittee hearing, the cases were managed by Kentucky Organ Donor Affiliates, a procurement organization that handles donations in Kentucky and parts of Ohio and West Virginia, which has merged with another group and is now called Network for Hope.
Of the 351 cases in the investigation, more than 100 had 'concerning features, including 73 patients with neurological signs incompatible with organ donation,' HHS said in a news release Monday. At least 28 cases involved patients who may not have been deceased at the time the organ procurement process began, raising 'serious ethical and legal questions.'
'Our findings show that hospitals allowed the organ procurement process to begin when patients showed signs of life, and this is horrifying,' HHS Secretary Robert F. Kennedy Jr. said in the release. 'The organ procurement organizations that coordinate access to transplants will be held accountable. The entire system must be fixed to ensure that every potential donor's life is treated with the sanctity it deserves.'
Network for Hope has not responded to CNN's request for comment, but it says on its website that it is 'fully committed to transparency' and is in full compliance with all requirements of the Centers for Medicare & Medicaid Services, which regulates organ donation organizations. 'Our goal has always been and will remain to meet the highest ethical and medical standards in donation and transplantation.'
The investigation found patterns such as failures to follow professional best practices, to respect family wishes, to collaborate with a patient's primary medical team, and to recognize neurological function, suggesting 'organizational dysfunction and poor quality and safety assurance culture' in the Kentucky-area organization, according to a report from the Health Resources and Services Administration.
The investigation also found that the Kentucky-area organization and the Organ Procurement and Transplantation Network, which oversees the local groups, failed to 'adequately recognize and respond to poor patient care and quality practices,' the report says.
The organ procurement organization in Kentucky is one of 55 in the US, and since the federal review, the Health Resources and Services Administration said, it has received reports of 'similar patterns' of high-risk procurement practices at other organizations.
The agency is mandating system-level changes to safeguard potential organ donors across the US and said the Kentucky-area organization needed to conduct a 'full root cause analysis of its failures to follow internal protocols.' It also said the organization must adopt a formal procedure to halt a donation process if there are safety concerns.
Network for Hope says on its website: 'We are equally committed to addressing the recent guidance from the HRSA and we are already evaluating whether any updates to our current practices are needed.'
The federal investigation was launched after one case in Kentucky came to light during a congressional hearing in September.
In 2021, 33-year-old TJ Hoover was hospitalized after a drug overdose. He woke up in the operating room to find people shaving his chest, bathing his body in surgical solution and talking about harvesting his organs. Earlier that day, a doctor had declared him brain-dead, according to his medical records, even though he seemed to be reacting to stimuli, making eye contact and shaking his head.
Former staffers of the organ procurement organization who were involved in Hoover's case raised concerns that he wasn't brain-dead and should not have been on the operating table. The concerns were ignored, according to the federal investigation.
Staff told CNN that the procedure to take Hoover's organs stopped after a surgeon saw his reaction to stimuli. The Kentucky procurement organization told CNN last fall that it had reviewed the case and 'remains confident that accepted practices and approved protocols were followed.'
Hoover now lives with his sister in Richmond, Kentucky, and is undergoing extensive physical therapy and treatment, much of which is shared on TikTok in an effort to inspire others.
Congress has been investigating the nation's organ donation system for years. Tuesday's hearing is intended to determine what lessons could be learned from the investigation, what changes are necessary to make the system better and what challenges lie ahead.
One issue involves organs procured from patients who aren't brain-dead. Although most donations in the US come from people who are brain-dead, there are other circumstances in which a patient may become an organ donor. It's called donation after circulatory death, or DCD, and it has become much more common in recent years, although some experts question the ethics of the practice.
A donation after brain death is defined by the Organ Procurement and Transplantation Network as 'the organ recovery process that may occur following death by irreversible cessation of cerebral and brain stem function; characterized by absence of electrical activity in the brain, blood flow to the brain, and brain function as determined by clinical assessment of responses.'
DCD, by comparison, is when 'you've got somebody with essentially devastating illness or injury, and their family's decided to withdraw life support,' Dr. Robert Cannon, an associate professor of surgery and surgical director of the liver transplant program at the University of Alabama at Birmingham, told CNN last year after Hoover's case came to light.
Cannon was not involved in Hoover's case but was familiar with it because he testified about lapses in the organ procurement system at the House Energy and Commerce Oversight and Investigations Subcommittee hearing where the case came to light in September.
'Certainly, we have potential DCD donors with lots of reflexes,' Cannon said. 'But as long as the family knows this is what's happening with their loved one, this process is considered ethical and standard.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Pharmacy warning of unsustainable demand for weight loss medication
Pharmacy warning of unsustainable demand for weight loss medication

Yahoo

time3 hours ago

  • Yahoo

Pharmacy warning of unsustainable demand for weight loss medication

The National Pharmacy Association (NPA) has issued a warning that the burgeoning demand for weight loss injections may be unsustainable, citing a significant mismatch between public interest and clinical suitability for the treatments. The NPA, which represents over 6,000 independent community pharmacies, highlighted this concern. A poll commissioned by the association revealed that 21 per cent of respondents had attempted to access weight loss treatments in the past year, either online or directly from a pharmacy. This figure surged to 35 per cent among 16 to 34-year-olds, contrasting sharply with just seven per cent of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'

Bangladesh Proposes to Ban Safer Nicotine Products Under Foreign Influence, Ignoring Public Health Evidence and Regional Precedents
Bangladesh Proposes to Ban Safer Nicotine Products Under Foreign Influence, Ignoring Public Health Evidence and Regional Precedents

Business Upturn

time4 hours ago

  • Business Upturn

Bangladesh Proposes to Ban Safer Nicotine Products Under Foreign Influence, Ignoring Public Health Evidence and Regional Precedents

MANILA, Philippines, July 28, 2025 (GLOBE NEWSWIRE) — The Bangladesh Ministry of Health is pushing a new tobacco control bill that proposes a sweeping ban on all safer nicotine products (SNPs), including vaping devices and oral alternatives. Alarmingly, this move is being pursued without public consultation and under an interim government—raising serious concerns about transparency and accountability. Citing WHO FCTC Article 5.3, the Ministry is attempting to justify excluding public health experts, consumers, and harm reduction advocates from the policymaking process. According to a report by the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), this misuse of international guidance is designed to block dissent and suppress scientific debate. The proposal appears to be heavily influenced by foreign actors—most notably Bloomberg Philanthropies and its primary grantee, the U.S.-based Campaign for Tobacco-Free Kids (CTFK). Since 2008, Bloomberg Philanthropies has channelled over US$232 million to CTFK to promote anti-nicotine policies worldwide. These funds support NGOs, train bureaucrats, and embed advisors within government ministries, creating a network of influence that sidelines national sovereignty. In Bangladesh, Bloomberg partner Vital Strategies maintains a Dhaka office staffed by former government officials, while CTFK and its affiliates are listed as official partners of the Ministry's National Tobacco Control Cell. This arrangement allows foreign-funded groups to shape policy directly, with little regard for democratic process or public health realities on the ground. 'This is not tobacco control. This is policy outsourcing,' said Nancy Loucas, Executive Coordinator of CAPHRA. 'Bangladesh risks allowing foreign-funded NGOs to override its own democratic institutions and deny its citizens access to proven harm reduction tools.' The move contradicts regional trends. Similar foreign-backed proposals were recently rejected in Pakistan and the Philippines , where authorities prioritized evidence-based public health approaches over external influence. The dangers of banning SNPs are already visible elsewhere. Countries like India and Australia, which have implemented such bans, are now dealing with rampant black markets and unregulated products—problems that undermine rather than improve public health. With one of the highest rates of tobacco-related illness in the world, Bangladesh stands to benefit greatly from a regulated harm reduction strategy. The global evidence is clear: SNPs help smokers quit and significantly reduce harm. A blanket ban would be a step backward, not forward. Contact: N.E Loucas [email protected] WhatsApp: 64 0272348463

How running for 75 minutes a week could help you live longer — and feel younger
How running for 75 minutes a week could help you live longer — and feel younger

Yahoo

time4 hours ago

  • Yahoo

How running for 75 minutes a week could help you live longer — and feel younger

When you buy through links on our articles, Future and its syndication partners may earn a commission. It's no secret that regular exercise is good for your health, but new research has uncovered a fascinating link between running and biological aging. In a study of over 4,400 U.S. adults, researchers found that those who jogged or ran for at least 75 minutes per week had significantly longer leukocyte telomeres. That might sound like something out of a science textbook, but it's really just a fancy way of saying your cells look younger on the inside. Telomeres sit at the ends of your chromosomes and act like little caps that protect your DNA. The longer they are, the better off you tend to be when it comes to aging. If you're looking to get started or find the right shoes for your runs, check out our guide to the best running shoes for every type of runner. This Brooks sneaker offers excellent comfort and support for everyday runs. The 27% saving applies to the women's model, but you'll find the same deal on the men's version as well. Just double-check that your size and favorite color are included in the offer before Deal The magic number is 75 minutes a week The study used data from the National Health and Nutrition Examination Survey and grouped people into three categories based on how much they ran each week. Only those who hit 75 minutes or more saw significant benefits to their telomere length, even after researchers controlled for differences in age, lifestyle, and medical history. In fact, the difference was big enough to suggest runners could be roughly 12 years biologically younger than those who don't run regularly. People who ran less than that? Well, they pretty much looked the same as the non-runners. While the results are compelling, it's worth being cautious. The results come from a single snapshot in time and rely on people accurately reporting their exercise, which can sometimes be optimistic. Still, the message is clear and encouraging: making running a regular habit might just be one of the simplest ways to help your cells stay spry. How to make it work for you The best part is that 75 minutes per week breaks down to just over 10 minutes (and 43 seconds if we are being pernickety) a day. That's a realistic goal for many people. If you're just getting started, try alternating walking and running using a beginner-friendly approach like Jeffing. This run-walk method can help you build endurance while easing the impact on your joints. Our fitness editor Jane swapped running for 'Jeffing' for a week and found it surprisingly enjoyable. And if running isn't your thing, other vigorous activities like swimming, cycling, or cardio workouts could offer similar benefits. Whichever route you choose, the science is stacking up in favor of getting your heart rate up. Follow Tom's Guide on Google News to get our up-to-date news, how-tos, and reviews in your feeds. Make sure to click the Follow button. More from Tom's Guide Forget the sauna — soaking in a hot tub could be better for your health, says new study No, not crunches — trainer says these 5 bodyweight moves are the secret to building stronger abs Fibermaxxing is the latest gut health trend, but does it really work?

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store